Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Tuberculosis Treatment Market Size Growth Rate by Type
1.3.2 First Line Drugs
1.3.3 Second Line Drugs
1.3.4 Combination Drugs
1.4 Market Segment by Application
1.4.1 Global Tuberculosis Treatment Market Share by Application (2018-2025)
1.4.2 Hospital
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Treatment Market Size
2.1.1 Global Tuberculosis Treatment Revenue 2013-2025
2.1.2 Global Tuberculosis Treatment Sales 2013-2025
2.2 Tuberculosis Treatment Growth Rate by Regions
2.2.1 Global Tuberculosis Treatment Sales by Regions 2013-2018
2.2.2 Global Tuberculosis Treatment Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Tuberculosis Treatment Sales by Manufacturers
3.1.1 Tuberculosis Treatment Sales by Manufacturers 2013-2018
3.1.2 Tuberculosis Treatment Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Tuberculosis Treatment Revenue by Manufacturers (2013-2018)
3.2.2 Tuberculosis Treatment Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Tuberculosis Treatment Market Concentration Ratio (CR5 and HHI)
3.3 Tuberculosis Treatment Price by Manufacturers
3.4 Key Manufacturers Tuberculosis Treatment Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Tuberculosis Treatment Market
3.6 Key Manufacturers Tuberculosis Treatment Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 First Line Drugs Sales and Revenue (2013-2018)
4.1.2 Second Line Drugs Sales and Revenue (2013-2018)
4.1.3 Combination Drugs Sales and Revenue (2013-2018)
4.2 Global Tuberculosis Treatment Sales Market Share by Type
4.3 Global Tuberculosis Treatment Revenue Market Share by Type
4.4 Tuberculosis Treatment Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Tuberculosis Treatment Sales by Application
6 North America
6.1 North America Tuberculosis Treatment Breakdown Data by Company
6.2 North America Tuberculosis Treatment Breakdown Data by Type
6.3 North America Tuberculosis Treatment Breakdown Data by Application
6.4 North America Tuberculosis Treatment Breakdown Data by Countries
6.4.1 North America Tuberculosis Treatment Sales by Countries
6.4.2 North America Tuberculosis Treatment Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Tuberculosis Treatment Breakdown Data by Company
7.2 Europe Tuberculosis Treatment Breakdown Data by Type
7.3 Europe Tuberculosis Treatment Breakdown Data by Application
7.4 Europe Tuberculosis Treatment Breakdown Data by Countries
7.4.1 Europe Tuberculosis Treatment Sales by Countries
7.4.2 Europe Tuberculosis Treatment Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Tuberculosis Treatment Breakdown Data by Company
8.2 Asia Pacific Tuberculosis Treatment Breakdown Data by Type
8.3 Asia Pacific Tuberculosis Treatment Breakdown Data by Application
8.4 Asia Pacific Tuberculosis Treatment Breakdown Data by Countries
8.4.1 Asia Pacific Tuberculosis Treatment Sales by Countries
8.4.2 Asia Pacific Tuberculosis Treatment Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Tuberculosis Treatment Breakdown Data by Company
9.2 Central & South America Tuberculosis Treatment Breakdown Data by Type
9.3 Central & South America Tuberculosis Treatment Breakdown Data by Application
9.4 Central & South America Tuberculosis Treatment Breakdown Data by Countries
9.4.1 Central & South America Tuberculosis Treatment Sales by Countries
9.4.2 Central & South America Tuberculosis Treatment Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Treatment Breakdown Data by Type
10.2 Middle East and Africa Tuberculosis Treatment Breakdown Data by Application
10.3 Middle East and Africa Tuberculosis Treatment Breakdown Data by Countries
10.3.1 Middle East and Africa Tuberculosis Treatment Sales by Countries
10.3.2 Middle East and Africa Tuberculosis Treatment Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Tuberculosis Treatment
11.1.4 Tuberculosis Treatment Product Introduction
11.1.5 Sanofi Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Tuberculosis Treatment
11.2.4 Tuberculosis Treatment Product Introduction
11.2.5 Bayer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Tuberculosis Treatment
11.3.4 Tuberculosis Treatment Product Introduction
11.3.5 Eli Lilly Recent Development
11.4 Labatec Pharma
11.4.1 Labatec Pharma Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Tuberculosis Treatment
11.4.4 Tuberculosis Treatment Product Introduction
11.4.5 Labatec Pharma Recent Development
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Tuberculosis Treatment
11.5.4 Tuberculosis Treatment Product Introduction
11.5.5 Macleods Pharmaceuticals Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Tuberculosis Treatment
11.6.4 Tuberculosis Treatment Product Introduction
11.6.5 Mylan Recent Development
11.7 Novatis
11.7.1 Novatis Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Tuberculosis Treatment
11.7.4 Tuberculosis Treatment Product Introduction
11.7.5 Novatis Recent Development
11.8 Otsuka
11.8.1 Otsuka Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Tuberculosis Treatment
11.8.4 Tuberculosis Treatment Product Introduction
11.8.5 Otsuka Recent Development
11.9 Patheon
11.9.1 Patheon Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Tuberculosis Treatment
11.9.4 Tuberculosis Treatment Product Introduction
11.9.5 Patheon Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Tuberculosis Treatment
11.10.4 Tuberculosis Treatment Product Introduction
11.10.5 Pfizer Recent Development
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Tuberculosis Treatment Sales Channels
12.2.2 Tuberculosis Treatment Distributors
12.3 Tuberculosis Treatment Customers
13 Market Forecast
13.1 Global Tuberculosis Treatment Sales and Revenue Forecast 2018-2025
13.2 Global Tuberculosis Treatment Sales Forecast by Type
13.3 Global Tuberculosis Treatment Sales Forecast by Application
13.4 Tuberculosis Treatment Forecast by Regions
13.4.1 Global Tuberculosis Treatment Sales Forecast by Regions 2018-2025
13.4.2 Global Tuberculosis Treatment Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Tuberculosis Treatment Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Tuberculosis Treatment Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Tuberculosis Treatment Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Tuberculosis Treatment Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Tuberculosis Treatment Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Sanofi、Bayer、Eli Lilly、Labatec Pharma、Macleods Pharmaceuticals、Mylan、Novatis、Otsuka、Patheon、Pfizer
【免責事項】
https://www.globalresearch.jp/disclaimer